Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

August 31, 2014

Conditions
Healthy VolunteersPharmacologic Action
Interventions
DRUG

PQ912

from day2 up to day6 twice daily oral dose of PQ912

DRUG

Midazolam

single oral dose on day1 and day 6

DRUG

Omeprazole

single oral dose on day1 and day6

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit Ltd, Leeds

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Covance

INDUSTRY

lead

Vivoryon Therapeutics N.V.

INDUSTRY

NCT02190708 - Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole | Biotech Hunter | Biotech Hunter